DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • China
  • /
  • Materials
Author Program NEWCreate Narrative
002004 logo

Huapont Life Sciences Co.,Ltd. Stock Price

SZSE:002004 Community·CN¥8.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

002004 Share Price Performance

CN¥0
-4.96 (-100.00%)
​
CN¥0
-4.96 (-100.00%)
​
Price CN¥0
Fri, 11 Sep 26
Share Pricen/a

002004 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

2 Risks
2 Rewards
View Full Analysis

Huapont Life Sciences Co.,Ltd. Key Details

CN¥11.5b

Revenue

CN¥7.2b

Cost of Revenue

CN¥4.2b

Gross Profit

CN¥3.6b

Other Expenses

CN¥644.1m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.33
36.86%
5.61%
44.6%
View Full Analysis

About 002004

Founded
1992
Employees
11950
CEO
Hai An Zhang
WebsiteView website
www.huapont.com.cn

Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. It is involved in the production and sale of pharmaceutical preparations and raw materials. The company also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management products. In addition, it provides pesticide technical, intermediate and preparation products, and GLP registration technical services. Further, the company engages in the research and development, production, and sales of fine chemical products and polymer materials, as well as provides tourism services and agent for the promotion of preparation products. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co.,Ltd. in September 2015. Huapont Life Sciences Co.,Ltd. was founded in 1992 and is headquartered in Chongqing, China.

Recent 002004 News & Updates

Recent updates

No updates

Huapont Life Sciences Co.,Ltd. Competitors

603993 logo

CMOC Group

Symbol: SHSE:603993
Market cap: CN¥370.8b
002379 logo

Shandong Hongqiao Aluminum Industry Holding

Symbol: SZSE:002379
Market cap: CN¥236.6b
600309 logo

Wanhua Chemical Group

Symbol: SHSE:600309
Market cap: CN¥233.2b
600176 logo

China Jushi

Symbol: SHSE:600176
Market cap: CN¥177.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide